Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 1 to 10 of 186 resources
-
Summary report: Hepatitis C good practice roadshow, Kent - September 2018
This report provides a summary of the good practice hepatitis C roadshow held by HCV Action and Public Health England in Maidstone on 5th September 2018. The report includes summaries of the workshops held on the day and attendees' reflections and pledges for action.South East Reports & Research, Strategy & Planning PDF -
Hepatitis C in the UK 2018 Report
Public Health England's annual 'Hepatitis C in the UK' report is the key national reporting document for hepatitis C. This is the tenth such report and follows the WHO Global Health Sector Strategy on Viral Hepatitis 2016 to 2021 and the draft action plan for the health sector response to viral hepatitis in the WHO European region. The report is structured to support UK monitoring of the Global Health Sector Strategy goals and summarises the impact of UK action plans to drive down mortality from HCV and reduce the number of new infections.UK Reports & Research, Strategy & Planning PDF -
R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C
This research paper assesses the impact of (i) incentives for R&D based on providing Intellectual Property (IP) rights protection, (ii) market competition and (iii) other factors including healthcare policies on access to direct acting antivirals (DAA) for hepatitis C in Europe.UK, Rest of World Reports & Research PDF -
Public health guidance on active case finding of communicable diseases in prison settings
This document, produced by the European Centre for Disease Prevention and Control, provides guidance to EU/EEA member states on prevention and case-finding for communicable diseases, including hepatitis C, in prisons.UK, Rest of World Reports & Research, Strategy & Planning PDF -
Signposting the Way to Elimination by 2025
The Hepatitis C Coalition is an umbrella group of leading clinicians, patient organisations, professional groups, industry and other interested parties committed to the reduction of morbidity and mortality associated with hepatitis C and its eventual elimination. This collaborative strategy builds on the release of the All-Party Parliamentary Group on Liver Health's 'Eliminating Hepatitis C in England' report and Public Health England's 'Hepatitis C in England: 2018 Report', with the aim of coordinating action by the key stakeholders involved in delivering elimination.England Reports & Research, Strategy & Planning PDF -
In Good Health: A Report following the All Party Pharmacy Group’s 2018 Inquiry into Long Term Conditions
The All Party Pharmacy Group, a parliamentary group, held an inquiry into long term conditions in 2018. The Hepatitis C Trust was invited to give evidence as part of the inquiry and this report, produced following the inquiry, highlights the need to increase testing and treatment for hepatitis C in pharmacies. Pharmacy testing for hepatitis C on the Isle of Wight is also featured as a case study.UK Reports & Research PDF -
Summary report: Hepatitis C good practice roadshow, Oxford - June 2018
This report provides a summary of the good practice hepatitis C roadshow held by HCV Action and Public Health England in Oxford on 7th June 2018. The report includes summaries of the workshops held on the day and attendees' reflections and pledges for action.England, South East Reports & Research PDF -
HCV testing in NSP (Needle and Syringe Provision) Community Pharmacies Pilot (Phase 1)
This report from the London Joint Working Group on Substance Use and Hepatitis C (LJWG) provides results from a pilot project providing point of care testing for hepatitis C to people who inject drugs accessing needle and syringe programmes based at community pharmacies in London. Over half of participants tested positive for hepatitis C antibodies and 78% of those engaging with further assessment in secondary care had chronic hepatitis C and were hepatitis C RNA positive.England, Greater London Reports & Research PDF -
United Kingdom drug situation: Focal Point annual report 2017
The UK Focal Point on Drugs' (part of Public Health England) annual report on the United Kingdom drug situation, providing updates for 2017. The report contains details of hepatitis C prevalence and incidence rates among injecting drug users, levels of testing, diagnosis and treatment for hepatitis C and prevention efforts by UK governments.UK Reports & Research PDF -
Hepatitis B/C in the countries of the EU/ EEA: a systematic review of the prevalence among at-risk groups
This 2018 study provides estimates of hepatitis C (and hepatitis B) prevalence among people in prison, men who have sex with men (MSM) and people who inject drugs (PWID) in countries which are member states of the European Union and European Economic Area. This article has been republished by HCV Action under the terms of the Creative Commons license: http://creativecommons.org/licenses/by/4.0/UK, Rest of World Reports & Research PDF